PGEN vs TECH · rev $1.8M vs P/E 65, rev $1.22B
Precigen Inc (PGEN) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Precigen Inc (PGEN) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported PGEN revenue for 2023-06-30 was $1.8M. Net income was -$20.3M. Revenue was down 4.5% from 2023-03-31 to 2023-06-30. PGEN currently screens at market cap $419.2M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
PGEN currently screens at market cap $419.2M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the PGEN and TECH stock pages for the full models.
Not investment advice.